Market Segment: Interventional Immuno-Oncology Service
Linkedin: Immunophotonics LinkedIn Company ProfileEstimated Revenue: $10M
Estimated Employees: 50
Address: 4320 Forest Park Avenue, St. Louis MO
Description: Immunophotonics has developed an in situ therapeutic cancer vaccine (inCVAX) for the treatment of solid tumor cancers. inCVAX is an in vivo immunotherapy that activates a multitude of the immune system’s cells to ultimately induce a systemic antitumor ...
Business Profile
